The History of Terrorism
Preview
Open in TheBrain
FacetBiotech
Parents
Biotechnology companies of the United States
Children
Seth Klarman
When Biogen eventually tried a hostile takeover of the company bidding up the price to $14 a share, Abbott Laboratories asked for a $27 per share settlement for acquisition. Klarman's fund finished that year up +27%.